Neurology News

The FDA has approved a battery-powered rechargeable deep brain stimulation system for patients with Parkinson’s disease and other disorders such as essential tremor, epilepsy and dystonia, according to the manufacturer.

A clinical-stage biopharmaceutical company has reported new positive data from a 12-month long-term open label extension of the CNM-Au8 treatment arm in the HEALEY ALS Platform Trial.

Sleep fragmentation, rather than sleep duration or self-reported sleep quality, in early midlife was associated with worse executive function, fluency and cognition more than a decade later, according to research in Neurology.

In a phase 2 trial, reteplase was well tolerated with a similar efficacy and safety profile to that of alteplase as an alternative IV thrombolytic treatment for acute ischemic stroke, researchers reported.

K2 Medical Research has partnered with Magruder Eye Institute and RetiSpec in a research pilot to improve access to clinical trials, using AI-driven technology to prescreen eligible candidates in an eye care setting.

According to results of a recent survey, more than 80% of U.S.-based neurologists agreed that a major unmet need in confronting Huntington’s disease is halting neurodegeneration prior to the onset of symptoms.

Minimally invasive, nonsurgical local treatments could be a possible option for small cutaneous neurofibromas instead of surgical removal, according to a study.

Caregivers for those with Lennox Gastaut and Dravet syndrome reported that cannabidiol treatment led to improved nonseizure outcomes and reduced seizure burden, according to a study from Epilepsy Research.

Binge-watching a TV show and online shopping are common reasons adults stay up past their bedtimes, according to a survey conducted by the American Academy of Sleep Medicine.

The FDA has granted breakthrough device designation for CT-155, an investigational prescription digital therapeutic co-developed by Click Therapeutics and Boehringer Ingelheim to treat negative symptoms of schizophrenia.